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Objective: The objective was to compare the medium- and long-term outcomes for
pericardial monocusp valves, polytetrafluoroethylene (Gore-Tex, WLGore and Asso-
ciates Inc, Flagstaff, Ariz) 0.1-mm monocusp valves, and bileaflet 0.l-mm polytetra-
fluoroethylene valves and their efficiency in the right ventricular outlet.
Methods: We reviewed all hand-sewn right ventricular outlet valves created by the
author (Graham R. Nunn) in the setting of repaired tetralogy of Fallot or equivalent
right ventricular outlet pathology when the native pulmonary valve could not be pre-
served. The valves were assessed by serial transthoracic echocardiography and more
recently by magnetic resonance imaging angiography for late valve function. The bi-
leaflet polytetrafluoroethylene valves were constructed in a standardized fashion from
a semicircle of 0.1-mm polytetrafluoroethylene (the radius of which equaled the
length of the outflow tract incision) that gave a lengthened free edge to the leaflets,
central fixation of the free edge posteriorly just proximal to the branch pulmonary ar-
teries, and generous augmentation of the outflow tract with polytetrafluoroethylene
patch-plasty. The bileaflet configuration shortens the closing time against the poste-
rior wall, and the leaflets are forced to maintain their configuration without prolapse
into the right ventricular outlet. The valve can be generously oversized in young
children to try to avoid the need for replacement.
Results: A total of 54 patients met the selection criteria—22 patients received
fresh autologous pericardial monocusps, 7 patients received polytetrafluoroethylene
(0.1-mm) monocusps, and 25 patients received bileaflet polytetrafluoroethylene
(0.1-mm) outlet valves. The pericardial valves have the longest follow-up, and all
valves developed free pulmonary incompetence. Polytetrafluoroethylene monocusps
had reliable competence early after surgery but progressed to pulmonary incompe-
tence. The bileaflet polytetrafluoroethylene (0.1-mm) valves have remained compe-
tent with regurgitant fractions of only 5% to 30% (magnetic resonance imaging
angiography), and this has remained stable with time. The maximum follow-up for
these valves is 5 years. No stenosis or peripheral emboli have been recognized, and
no valves have been replaced to date.
Conclusion: Hand-sewn bileaflet polytetrafluoroethylene valves in the right ventricu-
lar outlet can reliably provide competence and maintain function in the medium term.
Their shape and size allow placement in young children with a reasonable expectation
that they will remain competent with growth of the native annulus and not require re-
placement. Their durability is superior to the pericardial and polytetrafluoroethylene
monocusp valves in this series.
R
elief of right ventricular (RV) outlet obstruction in congenital cardiac surgery
is an important principle, but it brings with it the dilemma of competence of
the RV outlet. Valves and valved conduits provide excellent competence and
short and medium-term relief of obstruction. However, biological tissues have shown
a distinct degenerative capacity in the RV outlet with a significant incidence of ob-
struction in time.
Monocusps have been seen as a simple method of providing competence in the RV
outlet that requires transannular patching in the perioperative period.1-4 This may
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translate into a safer perioperative period and more rapid re-
covery. Others have demonstrated this and confirmed the
preservation of some or all valve competence with time
when the valve is constructed of a 0.1-mm polytetrafluoro-
ethylene (PTFE) (Gore-Tex, WL Gore and Associates Inc,
Flagstaff, Ariz) sheet.1,5,6 Others have not found useful valve
function late after PTFE monocusp valve construction in the
RV outlet.3,7 Various modifications of valves constructed
using PTFE membrane have been described.1,8-10
Materials and Methods
All patients in whom a hand-sewn valve was created in the RV outlet
for pulmonary incompetence in a single surgeon’s (GRN) experience
have been reviewed. No institutional approval was required for this
procedure that has long been practiced and documented at our own
institution and reported widely in the literature (The children’s hos-
pital at Westmead). The series is consecutive with pericardial valves
inserted from February of 1992 to October of 1998, PTFEmonocusp
valves inserted from April of 1998 to November of 2002, and bicus-
pid valves inserted from June of 2003 to the present. One pericardial
monocusp valve overlaps the PTFE monocusp series.
Valves inserted were hand-sewn, untreated, autologous pericar-
dial monocusps, hand-sewn 0.1-mm PTFE monocusps, and hand-
sewn bicuspid 0.1-mm PTFE valves. The bicuspid valves were an
evolution of the PTFE monocusps. The addition of a posterior fixa-
tion suture allowed the valve shape to be changed to increase its abil-
ity to better coapt to the posterior outflow tract and to have a greater
opening orifice size without compromising its speed of opening and
closing within the cardiac cycle. These are the most recent valves in
the series. The indication for surgery, need for additional follow-up
procedures in the RV outlet, and assessment of the competence of
the valve by echocardiography in all patients and more recently
by magnetic resonance imaging (MRI) techniques in some patients
were evaluated. All patients received PTFE patch augmentations in
the RV outflow tract with only the width of the patch and therefore
the degree of augmentation varying. No patients received anticoagu-
lation or antiplatelet agents in the postoperative period. Patients re-
ceived outflow tract valves at the time of surgery when the native
valve was small and destroyed or rendered incompetent by intended
extensive outflow augmentation. This decision was made intraoper-
atively and was consistently applied throughout the study. Those pa-
tients with pulmonary atresia and ventricular septal defect with
continuity between the pulmonary artery and the right ventricle
that could be repaired as in tetralogy of Fallot were included. Those
patients requiring conduits to bridge pulmonary artery deficiency
were not included. Late valve insertion for dilating right ventricles
was performed after canvassing all options with patients and par-
ents, and informed consent was obtained preoperatively in all 13
cases.The Journal of ThoSurgical technique remained constant: full bypass support, bi-
caval venous cannulation, moderate hypothermia, cold blood cardi-
oplegic arrest of the heart, and closure of all septal defects before RV
outlet valve construction. Valve construction was included in the
ischemic period of the heart for the smaller children and was con-
structed with the heart perfused and beating for larger children.
The RV outlet area was exposed with the aid of retraction sutures.
Monocusps were constructed as described by others1 using fresh
autologous pericardium or 0.1-mm PTFE. Bicuspid valves were
constructed using 0.1-mm PTFE cut as a sector of a circle with
the radius of the circle equaling the length from the distal posterior
wall of the pulmonary artery where the leaflet is attached to the prox-
imal end of the incision in the RV outlet. This shape gives the max-
imum length to the free edge. This sector is folded, sutured distally
first with a pledgeted nonabsorbable suture, and then sutured to the
myocardium at the proximal end of the ventriculotomy before both
sides are attached to the edges of the ventriculotomy. This sequence
allows the patch to be shortened, if too large, proximally, and then
the 2 sides are adjusted for width to give a higher open valve in
the patient in whom more augmentation of the outlet is required.
The edges of the PTFE are sewn from the proximal to distal ventri-
culotomy and arteriotomy edges so the final position of the free
edges of the valve can be adjusted as the final step in valve creation
if necessary. The time taken to construct each valve was similar; the
valve (pericardial or PTFE) was sewn into the RV incision with
a separate suture line to that attaching the RV outlet patch in all
cases. The bicuspid PTFE valve was not more difficult to construct
and could be fashioned readily for all (native plus PTFE augmenta-
tion) outflow tract sizes (Figures 1–6).
Figure 1. Steps in fashioning the valve into the RV outlet.racic and Cardiovascular Surgery c Volume 136, Number 2 291
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enced in echocardiography in all cases at the time of routine follow-
up visits, with grading of valve competence reported as minimal,
mild, moderate, severe, or free of pulmonary regurgitation. MRI as-
sessments (13) were performed and reported independently by the
hospital’s radiologists.
Results
Fifty-four patients have had valves placed in the RV outflow
tract. Among these, 50 patients have undergone 1 operation,
with 18 patients receiving an autologous unfixed monocusp
at the time of their definitive repair.
Six patients received a 0.1-mm PTFE monocusp, 25 pa-
tients received a bicuspid 0.1-mm PTFE RV outlet valve
substitute, and 1 patient received an autologous bicuspid
pericardial valve substitute.
Five patients have undergone more than 1 operation on the
RV outlet. Four of these patients had first received a pericar-
dial monocusp valve, which were replaced in 2 patients with
a homograft (1 unstented porcine valve and 1 bicuspid PTFE
valve).
Figure 2. Finished bicuspid PTFE (Gore-Tex, WL Gore and Associ-
ates Inc, Flagstaff, Ariz) valve with augmented RV outlet.
Figure 3. The folded leaflets can be trimmed proximally in situ and
then sutured after fixing the distal free edge so the valve length is
accurate.
Figure 4. A vascular clamp is an excellent temporary adjunct to
help accurately fold the 2 leaflets and then adjust the valve size
depending on the need for a large or small patch augmentation
of the RV outlet.
Figure 5. Large patch augmentation requires longer leaflets to the
valve, and this can be easily achieved by the angulation of the vas-
cular clamp as the leaflets are folded.
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underwent replacement with a bicuspid PTFE valve. There-
fore, there are 27 bicuspid valves available for follow-up; 1
pericardial bicuspid valve and 21 pericardial monocusps
have follow-up, with 17 remaining in situ at this time. Seven
PTFE monocusps have follow-up, with 6 remaining in situ at
the present.
The RV outlet valve was placed in 39 patients with tetral-
ogy of Fallot, 1 patient with absent pulmonary valve tetral-
ogy, 4 patients with pulmonary atresia and ventricular
septal defect, 6 patients with pulmonary atresia and intact
ventricular septum, 3 patients with double outlet right ventri-
cle and severe pulmonary stenosis, and 1 patient with critical
pulmonary stenosis (Table 1).
Figure 6. Smaller patch augmentation requires smaller leaflets,
and the excess is easily trimmed off accurately before removing
the vascular clamp.The Journal of ThorA valve was first placed in the RV outlet at a median age of
1.18 years. Pericardial monocusps were placed at age 1.546
1.9 years (median 0.89 years); PTFE monocusp valves were
placed at age 0.83 6 0.43 years (median 0.94 years); and
PTFE bicuspid valves were placed at age 0.98 6 0.55 years
(median 1.1 years). Although these ages vary, the groups
were not statistically different because of the small sample
sizes.
Thirteen of the patients had their first valve inserted in the
RV outlet some time after their lesion had been ‘‘repaired’’
(Table 2). Valves were inserted in these 13 patients because
the right ventricle was dilating in 8 patients, there was an in-
creasing gradient in 4 patients, and there was an increasing
gradient and a dilating right ventricle in 1 patient.
For the group with pulmonary atresia and intact ventricu-
lar septum, including the patient with critical pulmonary ste-
nosis, 2 patients had increasing gradients and 3 patients
showed progressive dilatation of the right ventricle. There
were 7 patients in the tetralogy of Fallot group (including
the patient with absent pulmonary valve): 4 patients with di-
lating right ventricle, 1 patient with dilating right ventricle
and increasing gradient, and 2 patient with increasing gradi-
ents. The 1 patient with pulmonary atresia with ventricular
septal defect repair received a valve for a dilating right
ventricle.
Follow-up
Follow-up of the 54 cases shows that 1 child with pulmo-
nary atresia and intact septum who received a pericardial
monocusp at 2 days of age died perioperatively. One child
with well-repaired tetralogy of Fallot died 3 years after sur-
gery; the child developed viral myocarditis 6 months before
death.TABLE 1. Cardiac lesion, valve inserted and age at surgery for repair
Lesion No. Valve type Age at operation (y)
Tetralogy of Fallot 39 Pericardial monocusp 5 14;
PTFE (Gore-Tex, WL Gore and
Associates Inc, Flagstaff, Ariz)
monocusp 5 6; bileaflet
PTFE (Gore-Tex) 5 19
1.05 6 0.5 y Median 0.95 y
Tetralogy of Fallot Absent
pulmonary valve
1 Pericardial monocusp 5 1 0.24 y
Pulmonary atresia with
Ventricular septal defect
4 Pericardial monocusp 5 2;
PTFE monocusp 5 1;
bileaflet PTFE 5 1
2.2 6 1.25 y Median 1.8 y
Pulmonary atresia with intact
ventricular septum
6 Pericardial monocusp 5 3;
bileaflet PTFE 5 3
1.5 6 3.2 y Median 0.1 y
Double outlet right ventricle
with pulmonary stenosis
3 Pericardial monocusp 5 2;
bileaflet PTFE 5 1
1.5 6 0.4 y Median 1.2 y
Critical pulmonary stenosis 1 Bileaflet PTFE 5 1 2 d
Total 54acic and Cardiovascular Surgery c Volume 136, Number 2 293
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Table 3. Twenty-two pericardial monocusps were placed.
One child died postoperatively, and 17 pericardial mono-
cusps remain in place. Two patients have mild pulmonary in-
competence (12%), 4 patients have moderate incompetence
(25%), 9 patients have free incompetence (56.25%), and 1
patient has mild pulmonary stenosis (18 mm gradient)
(6.25%). The other 2 patients both have had serial echocardi-
ography, but no cardiologist reports have been issued; thus,
they are not reported. Four monocusps have been replaced,
2 with homografts, 1 with an unstented porcine valve, and
1 with a bicuspid PTFE valve.
Seven PTFE monocusps have been placed, 6 remained in
situ and 1 was replaced by a bicuspid PTFE valve. Of those
valves in place, 1 has mild pulmonary incompetence
(16.7%), 3 have moderate incompetence (50%), and 2 have
free pulmonary incompetence (33.3%). No significant out-
flow gradients exist by echocardiography in either the peri-
cardial or PTFE monocusp groups in follow-up.
Twenty-seven bicuspid PTFE valves are available for fol-
low-up. Twenty-five valves were inserted at the time of re-
pair, 1 valve replaced a pericardial monocusp, and 1 valve
replaced a PTFE monocusp.
Echocardiographic follow-up (Table 3) shows minimal to
mild pulmonary incompetence in 25 patients (92.6%) and
moderate pulmonary incompetence in 2 patients (7.4%).
None have free pulmonary incompetence. Thirteen of the pa-
tients (48%) have mild outflow gradients estimated at 10 to
25 mm Hg by echocardiography. Serial assessment of valve
competence after the early postoperative period has shown
little change with time in reported valve competence. MRI
has become available in the latter part of this series, and to
date 13 patients have been investigated. General anesthesia
was used for each study. These patients all have bicuspid
PTFE valves in place.
The MRI calculated regurgitant fraction of the substitute
PTFE bicuspid valve ranges from 4% to 29%, with an aver-
age regurgitant fraction of 14.7% 6 7.5% and a median re-
gurgitant fraction of 11.5% (Figures 7 and 8; Table 4).
Thirteen patients have been investigated by both echocar-
diography and MRI. Relatively good correlation was ob-
served between the 2 modalities, but the subjective nature
of echocardiography was evident in its inability to distinguish
minimal and mild incompetence. Both had similar MRI re-
gurgitant fractions. Larger patient numbers may give more
useful information about the relative accuracy of each assess-
ment modality.
Discussion
Free-hand insertion of valves in the RV outlet does allow
the valve to be readily tailored to the size and shape of
the outlet, and this is an advantage The position of the
free edge of the leaflet(s) is important with good approxima-
tion to the posterior pulmonary artery wall or distal RV out-
let essential for competence.8 Placing this intended point
further distally in the main pulmonary artery increases the
likelihood that the valve will be competent without prolapse
TABLE 2. Repaired lesions requiring late insertion of right
ventricular outlet valve
Patient lesion
Age first
''repaired''
Interval to RVOT
valve insertion
Pulmonary atresia intact
ventricular septum
2 d 7.9 y
Pulmonary atresia intact
ventricular septum
3 d 1.3 y
Pulmonary atresia intact
ventricular septum
13 d 14.2 y
Pulmonary atresia intact
ventricular septum
50 d 15.6 y
Pulmonary atresia with
ventricular septal defect
1.1 y 13.9 y
Critical pulmonary stenosis 5 d 2.4 y
Tetralogy of Fallot with
absent pulmonary valve
0.3 y 8.3 y
Tetralogy of Fallot 0.7 y 0.6 y
Tetralogy of Fallot 0.73 y 9.1 y
Tetralogy of Fallot 0.95 y 5.3 y
Tetralogy of Fallot 1 y 7.5 y
Tetralogy of Fallot 1.6 y 11.5 y
Tetralogy of Fallot 2.6 y 14.7 y
RVOT, Right ventricular outflow tract.
TABLE 3. Echocardiographic assessment of all valves inserted
RV outlet valve type
Average
follow-up, y
Median
follow-up, y
Percentage of group
with moderate to severe
pulmonary incompetence
Percentage of group
with mild pulmonary
incompetence
Pericardial monocusp valve 10.5 6 2.9 y 9.4 y (5.3–15 y) 88% 12%
PTFE (Gore-Tex, WL Gore and Associates Inc,
Flagstaff, Ariz) monocusp valve
6.7 6 1.25 y 6 y (4.5–7.7 y) 83% 17%
PTFE (Gore-Tex) bicuspid valve 2.6 6 1.1 y 2.7 y (0.7–4 y) 7% 93%
Pericardial bicuspid valve (1 case) 5.4 y 5.4 y 0% 100% (1 case)
RV, Right ventricular; PTFE, polytetrafluoroethylene.
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DFigure 7. Magnetic resonance images showing
competence of the bicuspid PTFE valve in the
lateral view and no interference to flow in systole
in the craniocaudal view. This valve has been in-
serted for dilatation the right ventricle after repair
of pulmonary atresia and closure of ventricular
septal defect 14 years previously.and increases the leaflet area, thus reducing the wall stress
in the leaflet and the likelihood that it will disrupt around
its margins.
The addition of a fixation suture at the free edge of the
leaflet posteriorly organizes leaflet motion between systole
and diastole, forces the free edge to coapt without prolapse,
and decreases the time it takes the 2 halves of the free edge
to move from fully closed to fully open positions. It also
allows a greater degree of overcorrection in size in the RV
outlet because the valve can be crafted to fill any outlet,
which can to a certain extent then accommodate growth.
The hinge point in the leaflets changes as the 2 leaflets
move from fully open to fully closed, and this may prevent
buildup of fibrinous material at a hinge point that in the
monocusp is fixed, as has been shown to be the point of fibrin
accumulation.1 Oversizing of the valve may superficially
suggest that a capacitance chamber is created in the RV sys-
tem that could reduce the volume delivered to the pulmonary
arteries by each RV systole. This is, however, not the case.
Each RV systole not only is ejected through the valve but
also empties the volume of blood on the pulmonary arterial
side of the leaflets as it forces them open. That volume is
added to the pulmonary flow for that systole and returns
from there to the pulmonary arterial side of the valve whenit closes, thus preserving systolic volume delivered to the
pulmonary arterial tree. This concept is similar to the volume
of blood required to fill sinuses of Valsalva that also does not
detract from systolic volumes delivered by ventricles. The bi-
cuspid PTFE valves have been durable in the medium term,
not lost competence in the follow-up period, and not resulted
in significant obstruction in the RV outlet; however, follow-
up is shorter for this group and longer term reassessment is
necessary. They may represent an advance over the mono-
cusp valves. No attempt has been made to compare these
valves with modifications with existing leaflets that others
have described but were not present in our series.
Conclusions
Hand-sewn valves constructed from 0.1-mm PTFE have not
shown structural deterioration or calcification in this series.
The valves fashioned as monocusps have lost their compe-
tence (88%) in almost all cases. The valves fashioned as bi-
cuspid valves using the same 0.1-mm PTFE membrane
have retained their competence (93%) in most cases, and
there has not been a deterioration in their function in the
period of follow-up (Table 3).
These bicuspid valves are readily fashioned in place and
do not require complex measurements or extensiveFigure 8. Magnetic resonance images in end sys-
tole and end diastole showing the bicuspid PTFE
valve with little movement of the fold between
the 2 halves of the leaflet throughout the cardiac
cycle attesting to the stability of the valve shape.
The distal placement of the valve free edge is ap-
parent, just proximal to the branch pulmonary ar-
tery origins. This is an infant with repaired
tetralogy of Fallot, and the oversizing of the valve
is evident together with preserved ventricular
function.
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DTABLE 4. Comparison of echocardiographic and MRI assessment of RV outlet valve
Patient operation date Years of follow-up Echocardiography reports: RV outlet valve
MRI regurgitant fraction:
RV outlet valve
September 2, 2004 2.7 Mild pulmonary incompetence 12.0%
September 8, 2004 2.6 Minimal pulmonary incompetence 16.0%
September 30, 2004 2.6 Mild pulmonary incompetence 23.0%
February 1, 2005 2.2 Mild pulmonary incompetence 11.5%
February 17, 2005 2.2 Mild plus pulmonary incompetence 18.0%
May 17, 2005 1.9 Mild pulmonary incompetence 18.0%
May 24, 2005 1.9 Moderate pulmonary incompetence 4.0%
October 15, 2005 1.5 Mild pulmonary incompetence 6.0%
October 20, 2005 1.5 Mild pulmonary incompetence 26.5%
December 1, 2005 1.4 No reports 10.0%
February 8, 2006 1.2 Minimal pulmonary incompetence 10.0%
February 15, 2006 1.2 Mild pulmonary incompetence 29.0%
August 23, 2006 0.7 Mild pulmonary incompetence 9.0%
RV, Right ventricular; MRI, magnetic resonance imaging.intraoperative time to reliably create. The size of the valve is
crafted to match the RV outlet regardless of the augmentation
size.
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Discussion
Dr J. Brown (Indianapolis, Ind). Dr Nunn and colleagues are to
be commended on their development of another relatively simple296 The Journal of Thoracic and Cardiovascular Surgery c Autechnique to reconstruct the pulmonary valve with 0.1-mm PTFE
membrane in patients who require a transannular patch. I have to
admit that studying their illustrations and seeing the video clarified
this technique immensely for me. Reading the abstract, I was a little
confused. But you did a wonderful job in explaining how this valve
works and how it’s oriented in the RV outflow tract.
This technique lengthens the leading edge, or free edge, of the
reconstructed pulmonary valve and has the potential advantage of
enlarging the pulmonary valve to a greater diameter than can be
accomplished with a monocusp valve and may shorten the leaflet
closing time. The technique also orients the commissures of the
new valve in a vertical manner as opposed to the monocusps, where
the closure is in the horizontal manner.
The monocusp technique, using this material that my colleagues
and I have used successfully at Indiana for more than 13 years and
more than 200 patients, allows us to double the circumference of the
native RV outflow tract, but it seems that this technique might allow
you to enlarge it even further. I have several questions. Do you use
aspirin postoperatively in your patients?
Dr Nunn. I haven’t.
Dr Brown. Can you make this outflow tract reconstruction too
large so that when you close the sternum it’s compressed and this
would deform this valve?
Dr Nunn. It’s possible. But I think that the bileaflets, because
they’re held apart by that pledgeted suture, would still function to
a degree with redundancy in their free edge, which is implied in
your question, so I think it would still work, but I haven’t had that
experience yet.
Dr Brown. There obviously is some artwork involved with this
technique to know how large to make the outflow tract patch itself.
Do you have a rule of thumb that you use for how big youmake it, or
how big of an orifice through this outflow tract you want to have at
the end of your repair?
Dr Nunn. I don’t have a rule of thumb. For the tetralogies re-
paired primarily that needed this, I’ve used a 25-mm wide PTFE
strip as the augmenting patch, but it can be larger.
Dr Brown. In at least 1 of your patients you had a 30% regurgi-
tant fraction in this bileaflet or bicuspid valve. What was the nature,gust 2008
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leakage in all of these valves? Where does the leakage occur?
Dr Nunn. With the technique of MRI used here in a number of
these patients, the normal mitral and aortic valves were assessed for
their competence, and they regularly returned a 5% regurgitant frac-
tion by this technique. So that a median regurgitant fraction of 11%
isn’t as bad as it may appear at first glance. That’s the first thing.
I think the other is that I don’t think I’ve made them all perfect,
and I’m sure there is a learning curve in that. I’m convinced that I’m
still learning. So whether the 30% valve was just a bad day, I don’t
know. When I started this, I thought that if they were going to fail
they were going to fail as a monocusp does, and I’d left the patient
with a reasonable chance of progressing to later growth and the need
for another type of valve, as most repaired tetralogies with outflow
tract patches have. So I felt comfortable that I could use this tech-
nique. I would have been happy at that point to accept a 30% regur-
gitant fraction. So to see them functioning sometimes at near-normal
valve competence, as assessed by this technique of MRI, I was very
happy with that.
Dr Brown. Our experience with a monocusp has been a little
better in that at approximately 12 years postoperatively there is
only moderate or greater regurgitation in approximately 50% at
12 years. It’s promising that at least this technique may reduce
that substantially, and for that I congratulate you for this new tech-
nique to further reduce the late development of pulmonary insuffi-
ciency in this important group of patients.
Dr G.-W. He (Hong Kong, China). Congratulations for an ele-
gant technique. My question is regarding the use of the monocusp
valve. It was used in the early 1970s and 1980s. The reason that
the monocusp was abandoned in the 1980s in most centers was
because it was not functioning after 6 months for 2 reasons: First,
some of the monocusps were absorbed, so it was not functioning.
Second, some of the monocusps were calcified, so was not function-
ing because it was attached to the wall.
This is why I developed a new technique to create a monocusp-
bearing pericardium patch. I reported this technique 2 days ago at
the World Society for Congenital Heart Surgery meeting. I do be-
lieve that the use of a monocusp-bearing patch cannot be abandoned
because in many of the patients who need RV outflow tract recon-
struction, there are some remnants of the native valves. In my prac-
tice, in the last few years, I did 74 tetralogy repairs. Two thirds of
them have at least 1 or 2 valves left. In such cases I do not think
we really need to go too far to use your bicuspid pericardial patch,The Journal of Thorwhich has a lot of foreign body tissue in the low pressure pulmonary
system that may need coagulation therapy. Do you really think your
technique can be used for all patients with tetralogy or do we still
need to use the monocusp?
Dr Nunn. Like you, I leave any useful valve remnants in the RV
outflow tract and that’s often 2 leaflets. So I share your desire to pre-
serve pulmonary valve tissue.
I haven’t seen any evidence of pulmonary emboli or thrombosis
in the RV outlet or pulmonary arteries in these patients in follow-up.
It may happen, but it hasn’t yet.
I agree with you that pericardial monocusps do deteriorate. In
this series, of the 22 pericardial monocusps, 5 were replaced, 1
with a bileaflet PTFE valve and 1 with homografts or freestyle por-
cine valves. My findings were that the monocusps were stuck to the
free wall.
Dr He. I used the monocusp valve formed from the pericardium
itself, fold up and sewn on the 2 sides. I think the results would
be better than the traditional method that uses 1 patch sewn to an-
other, because the calcification and the absorbable problem would
be less.
Dr J. Jacobs (St Petersburg, Fa). In 2005, JimQuintessenza and
I published our initial experience with 41 patients with PTFE bicus-
pid valves in older, larger patients. Our series is now up to 90 pa-
tients with a median age of 14.6 years, and our follow-up is about
up to 6.4 years; 88 of these 90 valves are still functional and 2 of
them had to be replaced. We initially used 0.6-mm PTFE, and
now we’ve switched to 0.1-mm PTFE.
Would you use the valve that you’ve described in an older pa-
tient, a teenager, with late pulmonary insufficiency? If so, would
you use 0.6-mm or 0.1-mm PTFE?
Dr Nunn.A number of these patients are in that age range. I still
use the 0.1-mm PTFE. The 0.6-mm PTFE just adds momentum to
the leaflets and stiffens the valve enough that it probably doesn’t
finish its opening or closing when the next cardiac cycle arrives.
So that’s one of the reasons I stayed with the 0.1. But having
done that, it’s a fragile membrane to work with, and so using a larger
leaflet extending well into the pulmonary artery spreads the wall
stress of the PTFE and allows tension to be taken off that posterior
fixing suture.
Dr Jacobs.Wewere initially using the 0.6. After discussion with
John Brown and having 1 failure when it got a little calcified, we
switched to the 0.1, and we’ve been pretty happy with that by mak-
ing a long leaflet just like you described.acic and Cardiovascular Surgery c Volume 136, Number 2 297
